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 Abstract
Objectives: Photodynamic therapy is one of the modern therapeutic techniques, in which cytotoxic effects are 
induced by light. Currently, investigators show that it can be used to eliminate cervical cancer cells. 
Aim: In this study we decided to check whether the Low Level Lasers Therapy (LLLT) can induce the phototoxic 
changes in HeLa cells, after their photosesitization.
Material and methods: The studies were performed in vitro on HeLa cervical cancer cell line. Protoporphyrin IX (PpIX) 
in final concentrations: 0.5, 1.0, 5.0 and 10.0μmol/l was used as photosensitizer. The cells were preincubated with 
specific concentrations for 6 and 18 hours. After these defined periods of time the cultures were illuminated for 8 
minutes by laser light (635nm and 30mW/cm2). The cytotoxic effects were assessed by a colorimetric test XTT, 24 
and 48 hours after irradiation.
Results: Significantly augmented cytotoxic changes were found in HeLa cells 18 hours after preincubation and 48 
hours after illumination. Moreover, biostimulating laser exposure preceded by preincubation with protoporphyrin IX 
caused the cytotoxic changes in cervical cancer cells. 
Conclusion: The obtained results allow us to assume that photodynamic therapy of cervical cancer using 
biostimulating laser light should be performed 18 hours after the application of protoporphyrin IX. 
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Introduction
Lasers	 –	 the	 source	 of	 coherent	 light	 –	 have	 been	 known	
since	 1960.	Their	 action	 is	 based	 on	 a	 stimulated	 emission	 of	
electromagnetic	radiation.	Laser	light	has	specific	properties,	such	




to	 categorize	 lasers	 into	high-powered	ones	 (power	 above	500	
W/cm2),	 used	 for	 tissue	 destruction	 and	 removal	 (cutting,	
vaporization	and	coagulation),	and	low-powered,	biostimulating	
ones	 (power	 below	 500W/cm2),	 used	 in	 physiotherapy,	 sports	
medicine,	dermatology,	rheumatology	and	dentistry	[2].	
Biostimulating	 lasers	 emit	 red	 and	 infrared	 light	 of	
wavelengths	from	632	to	about	900nm.	They	cause	no	thermal	
effects	in	tissue,	unlike	during	laser	surgery.	This	effect	is	called	
pre-thermal	 (specific)	 [3].	 In	 physiotherapy,	 biostimulating	
lasers	 are	 used	 for	 treatment	 of	 inflammatory	 conditions,	
such	 as	 rheumatic	 diseases,	 neuropathies,	 tendinitis,	 fascitis,	




of	 wounds,	 ulcerations	 and,	 in	 cases	 of	 improper	 healing,	 of	
bones	[2].	




[4].	 Three	 factors	 are	 used	 to	 achieve	 it:	 the	 substance	 with	
photosensitizing	 features,	 the	 photosensitizer,	 the	 light	 of	
appropriate	wavelength	and	 the	oxygen	 [5].	Used	 individually,	
each	of	 the	 factors	 should	be	harmless	 for	 tissue.	Their	 joined	
action	 causes	 toxic	 effect	 on	 tissues,	 based	 mainly	 on	 action	
of	free	radicals,	created	due	to	induction	of	photosensitizer	the	
light	 [6].	 PDT	 is	 used	 for	 the	 treatment	 of	 cancers,	 especially	
melanoma.	
Currently,	 there	 have	 appeared	 some	 scientific	 studies	
concerning	the	use	of	this	method	for	therapy	of	cervical	cancer,	









All	 chemicals	 were	 purchased	 from	 Sigma	 Chemical	
Company	(St.	Louis,	MO).	The	stock	solution	of	protoporphyrin	
IX	 (2.5mmol/l)	 was	 obtained	 by	 dissolution	 in	 dimethyl	
sulfoxide.	The	final	concentrations	(0,5;	1,0;	5,0	and	10,0μmol/l)	







2	mmol/l	 L-glutamine,	 100	 μg/ml	 streptomycin	 and	 100	U/ml	
penicillin	 in	 a	 5%	CO2-humidified	 atmosphere	 at	 37oC.	After	
24–48	 hours	 incubation	 the	 cells	 were	 transferred	 to	 96-well	
plates.	 The	 cells	 were	 rinsed	 off	 using	 96%	 solution	 of	 PBS	
(phosphate-buffered	 saline)	 and	 digested	 with	 0.05%	 trypsin	









Wstęp: Terapia fotodynamiczna jest jedną z nowych metod leczniczych, w których efekty cytotoksyczne są 
wywołane przez fotouczulacz po jego aktywacji światłem. Obecnie wskazuje się możliwość zastosowania tej 
metody w celu eliminacji komórek raka szyjki macicy. 
Cel badań: Celem niniejszych badań było sprawdzenie czy lasery niskoenergetyczne mogą zostać wykorzystane 
jako źródło wzbudzenia fotouczulaczy w komórkach raka szyjki macicy. 
Materał i metody: Badania przeprowadzono w warunkach in vitro na linii komórek raka szyjki macicy HeLa. Jako 
substancję fotouczulającą zastosowano protoporfirynę IX (PpIX) o końcowych stężeniach: 0,5, 1,0, 5,0 i 10,0mmol/l. 
Komórki preinkubowano z protoporfiryną IX przez okres 6 i 18 godzin. Po tych czasach zawartą w komórkach 
protoporfirynę IX aktywowano przez 8 minut światłem laserowym (635nm, 30mW/cm2). Komórki inkubowano 
dalsze 24 i 48 godzin a zmiany cytotoksyczne oceniano kolorymetrycznym testem XTT.
Wyniki: Zaobserwowano, że najwyższe efekty cytotoksyczne w komórkach HeLa można otrzymać podczas 18 
godzinnej preinkubacji oraz 48 godzinnej inkubacji po naświetlaniu. Wyniki wskazują na możliwość zastosowania 
laserów biostymulacyjnych w terapii fotodynamicznej komórek raka szyjki macicy.
Wnioski: Uzyskane wyniki pozwalają przypuszczać, że terapię fotodynamiczną raka szyjki macicy przy pomocy 
laserów niskoenergetycznych należy wykonać w czasie 18 godzin od momentu aplikacji protoporfiryny IX.
 Słowa kluczowe: rak szyjki macicy / in vitro / terapia fotodynamiczna / 
      / protoporfiryna IX / lasery niskoenergetyczne / 
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Photodynamic therapy treatment
HeLa	 cells	 were	 preincubated	 for	 6	 or	 18	 hours	 with	
protoporphyrin	 IX	 final	 concentrations	 as	 above.	 After	 this	














product.	 Intensity	 of	 the	 fluorescence	 was	 measured	 at	 the	
wavelength	of	450nm	[15].	
The	 percentage	 of	 mitochondrial	 activity	 inhibition	 was	
calculated	according	to	the	following	equation:	100−(OD	of	drug	









Influence of protoporphyrin IX concentration and 
preincubation periods on cytotoxic effects in HeLa 
cells/ 24-hour incubation






and,	after	 this	period,	we	assessed	 the	percentage	 inhibition	 in	
mitochondrial	activity	using	the	colorimetric	XTT	test.	
Results	 of	 cytotoxicity	 were	 joined	 and	 are	 graphically	
shown	in	Figures	1	and	2.			
Figures	 show	 the	 importance	 of	 preincubation	 time	 of	
cervical	 cancer	 cells	with	 protoporphyrin	 IX.	 In	 the	 case	 of	 a	
6-hour	 exposure	 of	 cells	 to	 photosensitizer,	 the	 inhibition	 in	
mitochondrial	activity	was	low	as	compared	to	the	control	group	
of	cells,	reaching	the	value	of	below	20%.	
Elongation	 of	 preincubation	 time	 to	 18	 hours	 caused	 a	
significantly	higher	cytotoxic	effect	as	compared	 to	 the	6-hour	




Influence of protoporphyrin IX concentation and 
preincubation periods on cytotoxic effects in HeLa 
cells/ 48-hours length of incubation
In	 order	 to	 assess	 influence	 of	 protoporphyrin	 IX	
concentration	 and	 preincubation	 periods	 on	 cytotoxic	 effects	
in	 HeLa	 cells,	 the	 cells	 were	 preincubated	 for	 6	 or	 18	 hours	
with	 different	 concentrations	 of	 PpIX.	After	 these	 periods	 the	






Similarly	 to	 the	 case	 of	 24-hour	 incubation,	 the	 figures	
demonstrate	 how	 important	 the	 time	 of	 preincubation	 cervical	
cancer	 cells	 with	 protoporphyrin	 IX	 was.	 In	 the	 case	 of	 the	
6-hour	 exposure	 of	 cells	 to	 photosensitizer,	 the	 percentage	 of	
mitochondrial	 activity	 inhibition,	 as	 compared	 to	 the	 control	
 
Figure 2. Preincubation time: 18 hours. 
 
Figure 1. Preincubation time: 6 hours. 
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group	 of	 cells,	 varied	 between	 20%	 and	 33%.	 Elongation	 of	
preincubation	 time	 to	 18	 hours	 caused	 a	 significantly	 higher	
cytotoxic	 effect	 as	 compared	 to	 the	 6-hour	 preincubation	









cellular	metabolism	 increases,	 as	 demonstrated	 by	 an	 increase	
in	 adenosine-5´-triphosphate	 (ATP),	 DNA	 and	 RNA	 contents,	
increase	in	the	membrane	enzyme	activity	and	improvement	in	
electrolyte	exchange	between	the	cell	and	external	environment.	









photosensitized	by	a	 special	 substance,	 the	photosensitizer.	An	
increase	 in	 the	 use	 of	 LLLT	 for	 treatment	 of	 cancer	 has	 been	












method	 with	 laser	 light	 is	 useful	 for	 destruction	 of	 cervical	






photometrically	 and	 it	 correlates	with	 the	number	of	 live	 cells	
[13].	




influence	 of	 PpIX	 on	 cytotoxicity	 is	 well	 shown	 in	 18-hour	
preincubation	and	48-hour	incubation.	On	the	basis	of	XTT	test	
results,	we	can	conclude	that	the	cytotoxic	effect	was	dependent	
on	 photosensitizer	 concentration	 and	 periods	 of	 preincubation	
and	incubation.	
What	 proved	 important	 was	 that	 each	 time	 the	 period	
of	 exposure	 to	 laser	 light	 was	 quite	 short	 (8	 minutes),	 which	




for	 therapy	 effectiveness	 involves	 application	 of	 the	 proper	
PpIX	concentration	and	an	appropriate	period	of	 time	between	





therapy	 is	 accepted	 as	 a	 form	of	 therapy	 of	 cervical	 cancer	 in	
Japan,	allow	us	to	accept	this	hypothesis	[14].	
 
Figure 4. Preincubation time: 18 hours. 
 
Figure 3. Preincubation time: 6 hours. 
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This	work	proves	the	effectiveness	of	photodynamic	therapy	
on	cancer	cells	in	in	vitro	conditions.	These	experiments	can	be	
treated	 as	 an	 introduction	 to	 the	 clinical	 use	 of	 photodynamic	
elimination	 of	 cancer	 cells.	An	 important	 problem	 will	 be	 to	
determine	whether	effective	elimination	of	cells	takes	place	also	
in	 in	vivo	conditions.	It	 is	necessary	 to	encourage	independent	
investigators	 to	 examine	 photodynamic	 therapy	 in	 order	 to	
improve	its	efficacy.
Conclusion
1.	 Photodynamic	 therapy	 is	 an	 effective	 method	 of	
destroying	cervical	cancer	cells.	




the	method	 is	 to	match	 appropriate	periods	of	 	 time	of	
preincubation	and	incubation	with	protoporphyrin	IX.
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